MindBio Therapeutics Develops Fatigue Prediction Model for High-Risk Workplaces

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company specializing in AI-driven voice analysis for drug and alcohol intoxication detection, is broadening its technology platform with a new fatigue prediction model designed for high-risk workplace environments. The company was recently featured in an article highlighting its efforts to develop a fatigue detection capability that will be integrated into its planned Edge AI Intoxication Detection Kiosks.

According to the article, “The fatigue detection capability is expected to become an additional feature within MindBio’s planned Edge AI Intoxication Detection Kiosks, which are being designed to identify signs of alcohol, drug impairment and fatigue from short voice samples.” This development reflects MindBio’s broader strategy to position voice analytics as a scalable alternative to conventional impairment screening methods such as breathalyzers, saliva tests, urine analysis and laboratory-based toxicology testing. Instead of relying on physical samples, the company’s platform analyzes speech characteristics captured through a microphone and processes the audio using machine learning models trained on large voice datasets.

The expansion into fatigue detection underscores the potential of voice analysis to address a critical safety concern in industries where fatigue can lead to accidents and injuries. By incorporating this capability into its kiosks, MindBio aims to provide a non-invasive, rapid screening tool that can be deployed in environments such as mining, aviation, construction and law enforcement. The company’s AI prediction model already uses over 50 million data points to predict alcohol intoxication with high accuracy based solely on voice input, and the addition of fatigue detection could further enhance its utility.

MindBio’s enterprise platform includes Edge-AI kiosks that integrate bespoke hardware and software for the detection of drug and alcohol intoxication. The fatigue prediction model is expected to complement these capabilities, offering employers a comprehensive solution for identifying impairment and fatigue in real-time. As the technology evolves, it could help reduce workplace accidents and improve overall safety protocols.

For more information about MindBio Therapeutics and its latest developments, visit the company’s newsroom at https://nnw.fm/MBQIF. To view the full article discussing the fatigue detection model, visit https://nnw.fm/5DDUT.